Document And Entity Information
Document And Entity Information - shares | 9 Months Ended | |
Sep. 30, 2023 | Nov. 14, 2023 | |
Document Information Line Items | ||
Entity Registrant Name | Jupiter Acquisition Corporation | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --12-31 | |
Entity Common Stock, Shares Outstanding | 6,011,192 | |
Amendment Flag | false | |
Entity Central Index Key | 0001817868 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Document Period End Date | Sep. 30, 2023 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q3 | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Shell Company | true | |
Entity Ex Transition Period | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity File Number | 001-39505 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 85-1508739 | |
Entity Address, Address Line One | 11450 SE Dixie Hwy | |
Entity Address, Address Line Two | Suite 105 | |
Entity Address, City or Town | Hobe Sound | |
Entity Address, State or Province | FL | |
Entity Address, Postal Zip Code | 33455 | |
City Area Code | (212) | |
Local Phone Number | 207-8884 | |
Entity Interactive Data Current | Yes | |
Units, each consisting of one share of Class A Common Stock and one-half of one Warrant | ||
Document Information Line Items | ||
Trading Symbol | JAQCU | |
Title of 12(b) Security | Units, each consisting of one share of Class A Common Stock and one-half of one Warrant | |
Security Exchange Name | NASDAQ | |
Class A Common Stock, par value $0.0001 per share | ||
Document Information Line Items | ||
Trading Symbol | JAQC | |
Title of 12(b) Security | Class A Common Stock, par value $0.0001 per share | |
Security Exchange Name | NASDAQ | |
Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 | ||
Document Information Line Items | ||
Trading Symbol | JAQCW | |
Title of 12(b) Security | Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 | |
Security Exchange Name | NASDAQ |
Condensed Balance Sheets
Condensed Balance Sheets - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Current assets | ||
Cash | $ 185,312 | $ 324,188 |
Prepaid expenses | 66,450 | 217,905 |
Income tax receivable | 1,883 | 10,156 |
Total current assets | 253,645 | 552,249 |
Marketable securities held in Trust Account | 15,305,996 | 159,610,253 |
TOTAL ASSETS | 15,559,641 | 160,162,502 |
Current liabilities | ||
Accrued expenses | 1,887,340 | 801,007 |
Total current liabilities | 1,887,340 | 801,007 |
Warrant liabilities | 245,355 | 490,713 |
Deferred tax liability | 321,707 | |
Excise tax payable | 1,451,815 | |
Deferred underwriting fee payable | 1,469,991 | 5,516,648 |
TOTAL LIABILITIES | 5,054,501 | 7,130,075 |
Commitments and Contingencies (Note 6) | ||
Class A common stock subject to possible redemption; 1,475,493 and 15,761,850 shares at redemption value at September 30, 2023 and December 31, 2022, respectively | 15,403,526 | 158,933,340 |
STOCKHOLDERS’ DEFICIT | ||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | ||
Additional paid-in capital | 698,186 | |
Accumulated deficit | (5,597,027) | (5,901,367) |
TOTAL STOCKHOLDERS’ DEFICIT | (4,898,387) | (5,900,913) |
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | 15,559,641 | 160,162,502 |
Class A Common Stock | ||
STOCKHOLDERS’ DEFICIT | ||
Common stock, value | 454 | 60 |
Class B Common Stock | ||
STOCKHOLDERS’ DEFICIT | ||
Common stock, value | $ 394 |
Condensed Balance Sheets (Paren
Condensed Balance Sheets (Parentheticals) - $ / shares | Sep. 30, 2023 | Dec. 31, 2022 |
Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | ||
Preferred stock, shares outstanding | ||
Class A Common Stock | ||
Common stock subject to possible redemption | 1,475,493 | 15,761,850 |
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, shares issued | 4,535,699 | 595,237 |
Common stock, shares outstanding | 4,535,699 | 595,237 |
Class B Common Stock | ||
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 10,000,000 | 10,000,000 |
Common stock, shares issued | 0 | 3,940,462 |
Common stock, shares outstanding | 0 | 3,940,462 |
Condensed Statements of Operati
Condensed Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Operating costs | $ 449,701 | $ 396,705 | $ 1,945,329 | $ 1,233,472 |
Loss from operations | (449,701) | (396,705) | (1,945,329) | (1,233,472) |
Other income: | ||||
Interest earned on marketable securities held in Trust Account | 249,491 | 672,213 | 2,319,875 | 818,225 |
Unrealized (loss) gain on marketable securities held in Trust Account | (52,767) | 27,589 | 13,602 | |
Change in fair value of warrant liabilities | (81,785) | 408,927 | 245,358 | 3,069,883 |
Reduction in deferred underwriter fee payable | 245,002 | |||
Total other income, net | 114,939 | 1,108,729 | 2,810,235 | 3,901,710 |
(Loss) Income before provision for income taxes | (334,762) | 712,024 | 864,906 | 2,668,238 |
Provision for income taxes | (42,553) | (129,314) | (560,566) | (129,314) |
Net (loss) income | $ (377,315) | $ 582,710 | $ 304,340 | $ 2,538,924 |
Class A Common Stock Redeemable | ||||
Other income: | ||||
Weighted average shares outstanding (in Shares) | 2,070,730 | 16,357,087 | 7,984,131 | 16,357,087 |
Basic and diluted net (loss) income per share (in Dollars per share) | $ (0.06) | $ 0.03 | $ 0.03 | $ 0.13 |
Class A Common Stock | ||||
Other income: | ||||
Weighted average shares outstanding (in Shares) | 3,940,462 | 2,367,164 | ||
Basic and diluted net (loss) income per share (in Dollars per share) | $ (0.06) | $ 0.03 | ||
Class B Common Stock Non-Redeemable | ||||
Other income: | ||||
Weighted average shares outstanding (in Shares) | 3,940,462 | 1,587,732 | 3,940,462 | |
Basic and diluted net (loss) income per share (in Dollars per share) | $ 0.03 | $ 0.03 | $ 0.13 |
Condensed Statements of Opera_2
Condensed Statements of Operations (Unaudited) (Parentheticals) - $ / shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Class A Common Stock Redeemable | ||||
Diluted weighted average shares outstanding | 2,070,730 | 16,357,087 | 7,984,131 | 16,357,087 |
Diluted net income per share | $ (0.06) | $ 0.03 | $ 0.03 | $ 0.13 |
Class A Common Stock | ||||
Diluted weighted average shares outstanding | 3,940,462 | 2,367,164 | ||
Diluted net income per share | $ (0.06) | $ 0.03 | ||
Class B Common Stock Non-Redeemable | ||||
Diluted weighted average shares outstanding | 3,940,462 | 1,587,732 | 3,940,462 | |
Diluted net income per share | $ 0.03 | $ 0.03 | $ 0.13 |
Condensed Statements of Changes
Condensed Statements of Changes in Stockholders’ Deficit (Unaudited) - USD ($) | Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Accumulated Deficit | Total |
Balance at Dec. 31, 2021 | $ 60 | $ 394 | $ (8,015,607) | $ (8,015,153) | |
Balance (in Shares) at Dec. 31, 2021 | 595,237 | 3,940,462 | |||
Net income (loss) | 781,675 | 781,675 | |||
Balance at Mar. 31, 2022 | $ 60 | $ 394 | (7,233,932) | (7,233,478) | |
Balance (in Shares) at Mar. 31, 2022 | 595,237 | 3,940,462 | |||
Balance at Dec. 31, 2021 | $ 60 | $ 394 | (8,015,607) | (8,015,153) | |
Balance (in Shares) at Dec. 31, 2021 | 595,237 | 3,940,462 | |||
Reduction of underwriting fee payable | |||||
Net income (loss) | 2,538,924 | ||||
Balance at Sep. 30, 2022 | $ 60 | $ 394 | (5,829,146) | (5,828,692) | |
Balance (in Shares) at Sep. 30, 2022 | 595,237 | 3,940,462 | |||
Balance at Mar. 31, 2022 | $ 60 | $ 394 | (7,233,932) | (7,233,478) | |
Balance (in Shares) at Mar. 31, 2022 | 595,237 | 3,940,462 | |||
Net income (loss) | 1,174,539 | 1,174,539 | |||
Balance at Jun. 30, 2022 | $ 60 | $ 394 | (6,059,393) | (6,058,939) | |
Balance (in Shares) at Jun. 30, 2022 | 595,237 | 3,940,462 | |||
Net income (loss) | 582,710 | 582,710 | |||
Balance at Sep. 30, 2022 | $ 60 | $ 394 | (5,829,146) | (5,828,692) | |
Balance (in Shares) at Sep. 30, 2022 | 595,237 | 3,940,462 | |||
Accretion to shares subject to redemption | (352,463) | (352,463) | |||
Balance at Dec. 31, 2022 | $ 60 | $ 394 | (5,901,367) | (5,900,913) | |
Balance (in Shares) at Dec. 31, 2022 | 595,237 | 3,940,462 | |||
Reduction of underwriting fee payable | 3,801,655 | 3,801,655 | |||
Remeasurement of Class A common stock subject to possible redemption | (1,239,625) | (1,239,625) | |||
Net income (loss) | 707,794 | 707,794 | |||
Balance at Mar. 31, 2023 | $ 60 | $ 394 | 2,562,030 | (5,193,573) | (2,631,089) |
Balance (in Shares) at Mar. 31, 2023 | 595,237 | 3,940,462 | |||
Balance at Dec. 31, 2022 | $ 60 | $ 394 | (5,901,367) | (5,900,913) | |
Balance (in Shares) at Dec. 31, 2022 | 595,237 | 3,940,462 | |||
Reduction of underwriting fee payable | 4,046,656 | ||||
Net income (loss) | 304,340 | ||||
Balance at Sep. 30, 2023 | $ 454 | 698,186 | (5,597,027) | (4,898,387) | |
Balance (in Shares) at Sep. 30, 2023 | 4,535,699 | ||||
Balance at Mar. 31, 2023 | $ 60 | $ 394 | 2,562,030 | (5,193,573) | (2,631,089) |
Balance (in Shares) at Mar. 31, 2023 | 595,237 | 3,940,462 | |||
Remeasurement of Class A common stock subject to possible redemption | (286,657) | (286,657) | |||
Conversion of Class B shares to Class A non-redeemable | $ 394 | $ (394) | |||
Conversion of Class B shares to Class A non-redeemable (in Shares) | 3,940,462 | (3,940,462) | |||
Net income (loss) | (26,139) | (26,139) | |||
Balance at Jun. 30, 2023 | $ 454 | 823,558 | (5,219,712) | (4,395,700) | |
Balance (in Shares) at Jun. 30, 2023 | 4,535,699 | ||||
Excise tax liability accrued for common stock redemptions | (1,451,815) | (1,451,815) | |||
Remeasurement of Class A common stock subject to possible redemption | (125,372) | (125,372) | |||
Net income (loss) | (377,315) | (377,315) | |||
Balance at Sep. 30, 2023 | $ 454 | $ 698,186 | $ (5,597,027) | $ (4,898,387) | |
Balance (in Shares) at Sep. 30, 2023 | 4,535,699 |
Condensed Statements of Cash Fl
Condensed Statements of Cash Flows (Unaudited) - USD ($) | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Cash Flows from Operating Activities: | ||
Net income | $ 304,340 | $ 2,538,924 |
Adjustments to reconcile net income to net cash used in operating activities: | ||
Change in fair value of warrant liabilities | (245,358) | (3,069,883) |
Interest earned on marketable securities held in Trust Account | (2,319,875) | (818,225) |
Unrealized gain on marketable securities held in Trust Account | (13,602) | |
Reduction in deferred underwriter fee payable | (245,002) | |
Deferred tax provision | (321,707) | |
Changes in operating assets and liabilities: | ||
Prepaid expenses | 151,455 | 13,637 |
Noncurrent prepaid insurance | 211,238 | |
Prepaid income taxes | 8,273 | |
Accrued expenses | 1,086,333 | 165,495 |
Income taxes payable | 129,314 | |
Net cash used in operating activities | (1,581,541) | (843,102) |
Cash Flows from Investing Activities: | ||
Cash withdrawn from Trust Account to pay franchise and income taxes | 1,442,665 | 142,000 |
Cash withdrawn from Trust Account in connection with redemption | 145,181,467 | |
Net cash provided by investing activities | 146,624,132 | 142,000 |
Cash Flows from Financing Activities: | ||
Payments of redemptions - Class A common stock | (145,181,467) | |
Net cash used in financing activities | (145,181,467) | |
Net Change in Cash | (138,876) | (701,102) |
Cash – Beginning of period | 324,188 | 1,351,816 |
Cash – End of period | 185,312 | 650,714 |
Supplementary cash flow information: | ||
Cash paid for income taxes | 874,000 | |
Non-Cash investing and financing activities: | ||
Remeasurement of Class A common stock to redemption value | (1,526,282) | (352,463) |
Reduction of deferred underwriting fee payable | (4,046,656) | |
Excise tax liability accrued for Class A common stock redemptions | $ 1,451,815 |
Description of Organization, Bu
Description of Organization, Business Operations and Going Concern | 9 Months Ended |
Sep. 30, 2023 | |
Description of Organization, Business Operations and Going Concern [Abstract] | |
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN | NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN Jupiter Acquisition Corporation (the “Company”) is a blank check company incorporated in Delaware on June 17, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2023, the Company had not commenced any operations. All activity for the period from June 17, 2020 (inception) through September 30, 2023 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the marketable securities held in the Trust Account (defined below). The registration statement for the Company’s Initial Public Offering was declared effective on August 12, 2021. On August 17, 2021, the Company consummated the Initial Public Offering of 15,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”) at $10.00 per Unit, generating gross proceeds of $150,000,000 which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 580,000 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to Jupiter Founders LLC (the “Sponsor”) and certain of the underwriters and certain of the underwriters’ employees, generating gross proceeds of $5,800,000, which is described in Note 4. On August 23, 2021, the underwriters notified the Company of their exercise of the over-allotment option in part and concurrent forfeiture of the remaining portion of such option. As such, on August 25, 2021, the underwriters purchased 761,850 additional Units at $10.00 per additional Unit upon the closing of the partial exercise of the over-allotment option, generating gross proceeds of $7,618,500. Simultaneously with the sale of the additional Units, the Company consummated the sale of an additional 15,237 Private Placement Units at $10.00 per additional Private Placement Unit, generating total gross proceeds of $152,370. Transaction costs amounted to $9,292,595, consisting of $3,152,370 of underwriting fees, net of reimbursement, $5,516,648 of deferred underwriting fees and $623,577 of other offering costs. On March 31, 2023, Nomura Securities International, Inc. (“Nomura”), an underwriter of the Initial Public Offering, agreed to waive its entitlement to the deferred underwriting commissions of $4,046,657 owed or payable to Nomura pursuant to the underwriting agreement for the Initial Public Offering (the “Underwriting Agreement”). As a result, the Company recognized $245,002 of other income attributable to the derecognition of deferred underwriting fees allocated to offering costs and $3,801,655 was recorded to additional paid-in capital in relation to the waiver of the deferred underwriting discount in the accompanying financial statements (see Note 6). On April 12, 2023, Brookline Capital Markets, a division of Arcadia Securities, LLC (“Brookline”) and Ladenburg Thalmann & Co. Inc. (“Ladenburg”), constituting all of the underwriters of the Initial Public Offering (other than Nomura), notified the Company pursuant to a letter dated as of April 6, 2023, that each of Brookline and Ladenburg agreed to waive its entitlement to the cash payment of deferred underwriting commissions owed or payable pursuant to the Underwriting Agreement and will each accept 150,000 common shares, totaling an aggregate of 300,000 common shares, which is approximately $4.90 per share, of the surviving company of the Company’s initial Business Combination in full satisfaction of the aggregate $1,469,991 that would be payable to such underwriters upon the closing of the Company’s initial Business Combination pursuant to the Underwriting Agreement. Following the closing of the Initial Public Offering on August 17, 2021, an amount of $150,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account established for the benefit of the Company’s Public Stockholders (as defined below) (the “Trust Account”), with Continental Stock Transfer & Trust Company acting as trustee (“Continental”), and was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 of the Investment Company Act that invest only in direct U.S. government treasury obligations, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below. A total of $7,618,500 of the net proceeds from the sale of the additional Units and the additional Private Placement Units was deposited in the Trust Account, bringing the aggregate proceeds held in the Trust Account to $157,618,500. In connection with the implementation of the Extension (as defined below) on April 20, 2023, as previously approved by the Company’s stockholders on April 18, 2023, the Company redeemed 14,286,357 shares of Class A common stock tendered for redemption by the Public Stockholders, at a redemption price of approximately $10.16 per share, for an aggregate redemption amount of approximately $145.2 million. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, including the partial exercise of the over-allotment option, and sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company must complete its initial Business Combination with one or more operating businesses with an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide the holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to the Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company may pay to the underwriters (as discussed in Notes 6 and 10). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and other holders of the Company’s common stock prior to the Initial Public Offering (the “Initial Stockholders”) have agreed to vote their Founder Shares (as defined in Note 5), Private Shares (as defined in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction. Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The Initial Stockholders have agreed (a) to waive their redemption rights with respect to the Founder Shares, Private Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. On April 18, 2023, the Company held a special meeting in lieu of the 2023 annual meeting of stockholders of the Company (the “Special Meeting”). At the Special Meeting, the Company’s stockholders approved, among other matters, (i) an amendment to the Certificate of Incorporation to extend the date by which the Company must consummate an initial Business Combination (the “Extension”) from August 17, 2023 to December 17, 2023, or such earlier date as determined by the Company’s board of directors (such applicable date, the “Extended Date”, and such amendment, the “Charter Amendment”), and (ii) an amendment to the Investment Management Trust Agreement, dated as of August 12, 2021, by and between the Company and Continental, to provide for the Extension to the Extended Date pursuant to the Charter Amendment (the “Trust Amendment”). Following the Special Meeting, on April 20, 2023, the Company filed the Charter Amendment with the Secretary of State of the State of Delaware in order to implement the Extension and entered into the Trust Amendment with Continental. In connection with the implementation of the Extension, (i) on April 20, 2023, all holders of Class B common stock voluntarily elected to convert all shares of Class B common stock to shares of Class A common stock on a one-for-one basis in accordance with the Certificate of Incorporation (collectively, the “Class B Conversion”), and (ii) the Company redeemed 14,286,357 shares of Class A common stock tendered for redemption by the Public Stockholders, at a redemption price of approximately $10.16 per share, for an aggregate redemption amount of approximately $145.2 million (the “Redemption”). Upon completion of the Class B Conversion and the Redemption, 6,011,192 shares of Class A common stock and no shares of Class B common stock remain issued and outstanding. In connection with the implementation of the Extension, the Company will have until December 17, 2023, or such earlier date as determined by the Company’s board of directors, to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The Initial Stockholders have agreed to waive their right to liquidating distributions from the Trust Account with respect to the Founder Shares and Private Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commissions (see Notes 6 and 10) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Going Concern As of September 30, 2023, the Company had $185,312 in its operating bank account and a working capital deficit of $1,731,225. As of September 30, 2023, $551,066 of the amount on deposit in the Trust Account represented interest income, which is available to pay the Company’s tax obligations. As of September 30, 2023, the Company withdrew an amount of $1,613,646 in the interest income from the Trust Account to pay tax obligations. Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. The Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor, or their affiliates, may, but are not obligated to, loan the Company additional funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain such additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s (“FASB”) Accounting Standards Update 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unable to complete a Business Combination by December 17, 2023, then the Company will cease all operations except for the purpose of liquidating. In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Codification Subtopic 205-40, “Presentation of Financial Statements – Going Concern,” the Company has until December 17, 2023 to consummate a Business Combination or effect an extension. It is uncertain that the Company will be able to consummate a Business Combination or effect an extension by this time. If a Business Combination is not consummated by this date and an extension has not been approved by the Company’s stockholders and effected, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and the mandatory liquidation, should a Business Combination not occur and an extension not be approved by the Company’s stockholders and effected, and potential subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 17, 2023. The Company intends to complete a proposed Business Combination before December 17, 2023. However, there can be no assurance that the Company will be able to consummate any Business Combination by such date. In addition, the Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, the Company may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through December 17, 2023. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these condensed financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these condensed financial statements. The funds in the Trust Account are invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds that meet certain conditions under Rule 2a-7 under the Investment Company Act and that invest only in direct U.S. government obligations. While short-term U.S. government treasury bills currently yield a positive rate of interest, they have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates below zero in recent years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the future adopt similar policies in the United States. In the event that the Company is unable to complete its initial Business Combination or makes certain amendments to the Certificate of Incorporation, the Public Stockholders are entitled to receive their pro-rata share of the proceeds held in the Trust Account, plus any interest income not released to the Company, net of taxes payable. Negative interest rates could impact the per share redemption amount that may be received by Public Stockholders. Consideration of Inflation Reduction Act Excise Tax On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote (including in connection with the Extension) or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote (including in connection with the Extension) or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. On April 20, 2023, the Company redeemed 14,286,357 shares of Class A common stock tendered for redemption by the Public Stockholders for a total redemption amount of $145,181,467 in connection with the implementation of the Extension. The Company evaluated the classification and accounting of the stock redemption under ASC 450, “Contingencies” to determine whether the Company should currently recognize an excise tax obligation associated therewith. ASC 450 states that when a loss contingency exists the likelihood that the future event(s) will confirm the loss or impairment of an asset, or the incurrence of a liability can range from probable to remote. Contingent liability must be reviewed at each reporting period to determine appropriate treatment. The Company evaluated whether a United States excise tax obligation should be recognized currently related to the stock redemption and concluded that this obligation should be recognized. As of September 30, 2023, the Company recorded $1,451,815 of excise tax liability calculated as 1% of shares redeemed on April 20, 2023. Any reduction to this liability resulting from either a subsequent stock issuance or an event giving rise to an exception that occurs within this tax year, will be recognized in the period (including an interim period) that such stock issuance or event giving rise to an exception occurs. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2023 | |
Summary of Significant Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in condensed financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on March 10, 2023. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the period ending December 31, 2023 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of September 30, 2023 and December 31, 2022, the Company had cash of $185,312 and $324,188, respectively. The Company did not have any cash equivalents at September 30, 2023 and December 31, 2022. Marketable Securities Held in Trust Account At September 30, 2023, substantially all of the assets held in the Trust Account were cash. At December 31, 2022, the assets held in the Trust Account were U.S. Treasury securities. From inception through September 30, 2023, the Company withdrew an amount of $1,613,646 in the interest income from the Trust Account to pay tax obligations. Offering Costs Offering costs consist of underwriting, legal, accounting and other expenses incurred through the condensed balance sheet date that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to derivative warrant liabilities are expensed as incurred in the statements of operations. Offering costs associated with the Class A common stock issued were initially charged to temporary equity and then accreted to common stock subject to redemption upon the completion of the Initial Public Offering. Offering costs amounted to $9,292,595, of which $8,938,077 were charged to stockholders’ equity upon the completion of the Initial Public Offering and $354,518 were expensed to the statements of operations. Warrant Liabilities The Company accounts for the Public Warrants (as defined in Note 3) and the Private Warrants (as defined in Note 4) (collectively, with the Public Warrants, the “Warrants”) in accordance with the guidance contained in FASB Accounting Standards Codification (“ASC”) Topic 480 and FASB ASC Topic 815 “Derivatives and Hedging” (“ASC 815”) under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statements of operations. On August 17, 2021 and subsequently on September 30, 2021, the Public Warrants were valued using a Monte Carlo Simulation model. The Private Warrants were valued using a Black Scholes model at December 31, 2021. For periods subsequent to the detachment of the Public Warrants from the Units including September 30, 2023, the close price of the Public Warrant price was used as the fair value as of each relevant date. In addition, as of September 30, 2023, the closing price of the Public Warrants was determined to be an appropriate estimate for the fair value of Private Warrants due to a make-whole provision in the contractual terms of the Warrant Agreement. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement’s carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2023 and December 31, 2022, 1,475,493 and 15,761,850 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, respectively, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. On April 20, 2023, the Company redeemed 14,286,357 shares of Class A common stock tendered for redemption by the Public Stockholders for a total redemption amount of $145,181,467 in connection with the implementation of the Extension, which is described in Note 1. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit. At September 30, 2023 and December 31, 2022, the Class A common stock reflected in the condensed balance sheets is reconciled in the following table: Shares Value Gross proceeds 15,761,850 $ 157,618,500 Less: Proceeds allocated to Public Warrants — (6,018,995 ) Class A common stock issuance costs — (8,768,627 ) Plus: Remeasurement of Class A common stock subject to possible redemption — 16,102,462 Class A common stock subject to possible redemption 12/31/22 15,761,850 158,933,340 Less: Redemption (14,286,357 ) (145,181,467 ) Plus: Remeasurement of Class A common stock subject to possible redemption — 1,651,653 Class A common stock subject to possible redemption 09/30/23 1,475,493 $ 15,403,526 Net (Loss) Income per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per common share is computed by dividing net income by the weighted average number of shares of common stock outstanding for the period. Remeasurement associated with the redeemable shares of Class A common stock is excluded from net (loss) income per common share as the redemption value approximates fair value. The calculation of diluted (loss) income per share does not consider the effect of the Warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the Warrants is contingent upon the occurrence of future events. The Warrants are exercisable to purchase 8,178,543 shares of Class A common stock in the aggregate. As of September 30, 2023 and 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common shares and then share in the net (loss) income of the Company. As a result, diluted net (loss) income per common share is the same as basic net (loss) income per common share for the periods presented. The following table reflects the calculation of basic and diluted net (loss) income per common share (in dollars, except per share amounts): For the Three Months For the Nine Months Ended September 30, Ended September 30, 2023 2022 2023 2022 Class A Common Stock subject to possible redemption Numerator: Net (loss) income allocable to Class A common stock $ (129,977 ) $ 469,586 $ 203,525 $ 2,046,030 Denominator: Weighted Average Class A common stock Basic and diluted weighted average shares outstanding 2,070,730 16,357,087 7,984,131 16,357,087 Basic and diluted net income (loss) per share $ (0.06 ) $ 0.03 $ 0.03 $ 0.13 Class A Common Stock Numerator: Net loss allocable to Class A common stock (247,338 ) — 60,342 — Denominator: Weighted Average Class A common stock - 3,940,462 — 2,367,164 — Basic and diluted net income (loss) per share $ (0.06 ) $ — $ 0.03 $ — Class B Common Stock Numerator: Net (loss) income allocable to Class B common stock — 113,124 40,473 492,894 Denominator: Weighted Average Class B common stock - Basic and diluted weighted average shares outstanding — 3,940,462 1,587,732 3,940,462 Basic and diluted net income per share $ — $ 0.03 $ 0.03 $ 0.13 Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature, except for warrant liabilities (see Note 9). Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. |
Initial Public Offering
Initial Public Offering | 9 Months Ended |
Sep. 30, 2023 | |
Initial Public Offering [Abstract] | |
INITIAL PUBLIC OFFERING | NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 15,761,850 Units at a purchase price of $10.00 per Unit, including 761,850 additional Units pursuant to the underwriters’ partial exercise of their over-allotment option. Each Unit consists of one share of Class A common stock and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50, subject to adjustment (see Note 8). |
Private Placement
Private Placement | 9 Months Ended |
Sep. 30, 2023 | |
Private Placement [Abstract] | |
PRIVATE PLACEMENT | NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering and the closing of the partial exercise of the over-allotment option, the Sponsor and certain of the underwriters and certain of the underwriters’ employees purchased an aggregate of 595,237 Private Placement Units at a price of $10.00 per Private Placement Unit for an aggregate purchase price of $5,952,370 in private placements. Each Private Placement Unit consists of one share of Class A common stock (“Private Share”) and one-half of one warrant (each, a “Private Warrant”). Each whole Private Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment. A portion of the proceeds from the Private Placement Units were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Units and all underlying securities will expire worthless. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Units or the underlying securities. |
Related Party Transactions
Related Party Transactions | 9 Months Ended |
Sep. 30, 2023 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On July 7, 2020, the Initial Stockholders purchased 5,750,000 shares of the Company’s Class B common stock (the “Founder Shares”) for an aggregate price of $25,000. On July 23, 2021, the Sponsor forfeited 1,437,500 Founder Shares resulting in an aggregate of 4,312,500 Founder Shares outstanding. The Sponsor agreed to transfer to certain of the underwriters and certain of their employees an aggregate of 240,001 shares of Class B common stock. All shares and per-share data has been retroactively restated. The Founder Shares included an aggregate of up to 562,500 Founder Shares that were subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part. On August 23, 2021, the underwriters notified the Company of their exercise of the over-allotment option in part and concurrent forfeiture of the remaining portion of such option. As such, on August 25, 2021, the underwriters purchased 761,850 additional Units at $10.00 per additional Unit upon the closing of the partial exercise of the over-allotment option. As a result of the underwriters’ election to partially exercise their over-allotment option and the forfeiture of the remaining portion of such over-allotment option, an aggregate of 372,038 Founder Shares were forfeited and 190,462 Founder Shares are no longer subject to forfeiture, resulting in an aggregate of 3,940,462 Founder Shares outstanding at August 25, 2021. The Initial Stockholders have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Of the aggregate 15,761,850 Units sold in the Initial Public Offering, 13,365,000 Units were purchased by certain qualified institutional buyers or institutional accredited investors that are not affiliated with the Company, the Sponsor, the Company’s directors or any member of the Company’s management team (the “Anchor Investors”). In connection with the closing of the Initial Public Offering, the Anchor Investors each acquired from the Sponsor an indirect economic interest in 100,000 Founder Shares (or an aggregate of 900,000 Founder Shares) at the original purchase price that the Sponsor paid for the Founder Shares. The Sponsor has agreed to distribute such Founder Shares to the Anchor Investors after the completion of a Business Combination. The Company estimated the aggregate fair value of the Founder Shares attributable to the Anchor Investors to be $4,464,000, or $4.96 per share. The fair value of the Founder Shares was valued using a binomial/lattice model. The excess of the fair value of the Founder Shares was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, the offering cost was allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs related to the Founder Shares amounted to $4,464,000, of which $170,341 were expensed in the statements of operations and included in transactions costs attributable to warrant liabilities and the remaining $4,296,659 netted to additional paid in capital resulting in only a charge to accumulated deficit of $170,341. On April 20, 2023, pursuant to the Class B Conversion, the Founder Shares were converted from shares of Class B common stock to shares of Class A common stock on a one-for-one basis in accordance with the Certificate of Incorporation. At September 30, 2023, there were 6,011,192 and 0 shares of Class A common stock and Class B common stock issued and outstanding, respectively. Administrative Services Agreement The Company entered into an agreement on August 12, 2021, through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor an aggregate of $15,000 per month for office space, utilities and secretarial and administrative support. For the three and nine months ended September 30, 2023, the Company incurred and paid $45,000 and $135,000, respectively, in fees for these services. For the three and nine months ended September 30, 2022, the Company incurred and paid $45,000 and $135,000 in fees for these services, respectively. Promissory Note — Related Party On June 24, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $250,000. The Promissory Note was subsequently amended on December 31, 2021 and 2020 to extend the maturity date. The Promissory Note was non-interest bearing and payable on the earlier of (i) December 31, 2021 and (ii) the consummation of the Initial Public Offering. As of September 30, 2023 and December 31, 2022, there were no amounts outstanding under the Promissory Note. The outstanding balance under the Note was repaid at the closing of the Initial Public Offering on August 17, 2021, and the Promissory Note was terminated. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be converted into units at a price of $10.00 per unit at the option of the lender. The units would be identical to the Private Placement Units. As of September 30, 2023 and December 31, 2022, there were no Working Capital Loans outstanding. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2023 | |
Commitments Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIE | NOTE 6. COMMITMENTS AND CONTINGENCIES Registration Rights Pursuant to a registration rights agreement entered into on August 12, 2021, the holders of the Founder Shares, Private Placement Units, Private Shares, Private Warrants, and units that may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Warrants and warrants included in the units that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Company’s Class A common stock). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. Notwithstanding the foregoing, the underwriters may not exercise their demand and “piggy-back” registration rights after August 12, 2026 and August 12, 2028, respectively, and may not exercise their demand rights on more than one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option beginning August 12, 2021 to purchase up to 2,250,000 additional Units to cover over-allotments, at the Initial Public Offering price less the underwriting discounts and commissions. On August 23, 2021, the underwriters notified the Company of their exercise of the over-allotment option in part and concurrent forfeiture of the remaining portion of such option. As such, on August 25, 2021, the underwriters purchased 761,850 additional Units upon the closing of the partial exercise of the over-allotment option. The underwriters were entitled to a deferred fee of $0.35 per Unit, or $5,516,648 in the aggregate, pursuant to the terms of the Underwriting Agreement, which deferred fee would (i) become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination and (ii) be waived by the underwriters in the event that the Company does not complete a Business Combination. On March 31, 2023, Nomura agreed to waive its entitlement to the deferred underwriting commissions of $4,046,657 owed or payable to Nomura in accordance with the Underwriting Agreement. As a result, the Company recognized $245,002 of other income attributable to the derecognition of deferred underwriting fees allocated to offering costs and $3,801,655 was recorded to additional paid-in capital in relation to the waiver of the deferred underwriting discount in the accompanying financial statements. On April 12, 2023, Brookline and Ladenburg, constituting all of the underwriters of the Initial Public Offering (other than Nomura), notified the Company pursuant to a letter dated as of April 6, 2023, that each of Brookline and Ladenburg agreed to waive its entitlement to the cash payment of deferred underwriting commissions owed or payable pursuant to the Underwriting Agreement and will each accept 150,000 common shares, totaling an aggregate of 300,000 common shares, which is approximately $4.90 per share, of the surviving company of the Company’s initial Business Combination in full satisfaction of the aggregate $1,469,991 that would be payable to such underwriters upon the closing of the Company’s initial Business Combination pursuant to the Underwriting Agreement. Legal Services Agreement Services rendered by the Company’s legal counsel are accrued on an ongoing basis but deferred for settlement until the closing of an initial Business Combination. The accrued fees were $1,555,000 and $758,955 as of September 30, 2023 and December 31, 2022, respectively. Business Combination Agreement On July 18, 2023, the Company, 1427702 B.C. Ltd., a corporation organized under the laws of British Columbia (“TopCo”), Filament Merger Sub LLC, a Delaware limited liability company and a direct, wholly-owned subsidiary of TopCo, and Filament Health Corp., a corporation organized under the laws of British Columbia (“Filament”), entered into a business combination agreement (as may be amended, supplemented, or otherwise modified from time to time, the “Business Combination Agreement”), which provides for a proposed business combination through a series of related transactions (the “Proposed Business Combination”). The consummation of the Proposed Business Combination is subject to a number of conditions set forth in the Business Combination Agreement including, among others, receipt of the requisite approval of the Company’s stockholders and execution of various transaction agreements. There can be no assurance as to whether or when the Proposed Business Combination will be consummated. On August 14, 2023, TopCo filed with the SEC a registration statement on Form F-4 (File No. 333-273972) (as subsequently amended, the “Form F-4”) in connection with the Proposed Business Combination, which contains a preliminary proxy statement/prospectus that constitutes (i) a preliminary prospectus relating to the offer of TopCo securities to be issued in the Proposed Business Combination and (ii) a preliminary proxy statement in connection with the solicitation of proxies for a special meeting of the Company’s stockholders to be held to approve the Proposed Business Combination and other matters as described in the Form F-4. Shareholder Support Agreements Concurrently with the execution and delivery of the Business Combination Agreement, certain Filament shareholders collectively holding approximately 43% of the total number of outstanding Filament Shares (the “Key Filament Shareholders”) executed and delivered to Jupiter certain voting and support agreements (the “Shareholder Support Agreements”), pursuant to which each such Key Filament Shareholder agreed to, among other things, (a) not transfer their Company Securities (as defined in the Shareholder Support Agreements), (b) support and vote in favor of the Business Combination and related matters and (c) not exercise, and waive, rights in respect of certain dissent rights, in each case, on the terms and subject to the conditions set forth in the Shareholder Support Agreements. Sponsor Support Agreement Concurrently with the execution and delivery of the Business Combination Agreement, the Company and the Sponsor executed and delivered to Filament a sponsor support agreement (“the Sponsor Support Agreement”), pursuant to which, among other things, the Sponsor (a) will vote the shares of the Company’s Common Stock held by it as of the date of the Sponsor Support Agreement and any additional equity securities of the Company that it acquires prior to the Company’s special meeting of stockholders to be held to approve the Proposed Business Combination, in each case, in favor of the Business Combination Agreement and each of the proposals to be presented to stockholders at such meeting, (b) will not redeem any shares of the Company’s Common Stock held by the Sponsor in connection with the Proposed Business Combination and will waive its redemption rights, (c) will convert, on the same terms and price as any PIPE investors, into equity the amount, if any, by which outstanding Working Capital Loans to the Company, if any, exceed $500,000, concurrently with the closing of the Proposed Business Combination (the “Closing”), and (d) if mutually agreed by Filament and the Company, will take such actions as may be necessary for the Company to further extend (including payment by the Company of any extension expenses), subject to stockholder approval, the duration of the Company’s timeline to consummate a business combination on terms mutually agreeable to Filament and the Company, if and to the extent necessary to consummate the Proposed Business Combination, in each case, on the terms and subject to the conditions set forth in the Sponsor Support Agreement. |
Stockholders_ Deficit
Stockholders’ Deficit | 9 Months Ended |
Sep. 30, 2023 | |
Stockholders’ Deficit [Abstract] | |
STOCKHOLDERS’ DEFICIT | NOTE 7. STOCKHOLDERS’ DEFICIT Preferred Stock Class A Common Stock Class B Common Stock If any shares of Class B common stock are then outstanding, only holders of Class B common stock have the right to vote on the election of directors prior to the Company’s initial Business Combination. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all other matters submitted to a vote of the Company’s stockholders except as otherwise required by law. The shares of Class B common stock (if any) will automatically convert into shares of Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon completion of the Initial Public Offering (not including the Private Shares underlying the Private Placement Units) plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). On April 20, 2023, pursuant to the Class B Conversion, the Founder Shares were converted from shares of Class B common stock to shares of Class A common stock on a one-for-one basis in accordance with the Certificate of Incorporation. At September 30, 2023, there were 6,011,192 and 0 shares of Class A common stock and Class B common stock issued and outstanding, respectively. The converted shares have the same restrictions as the Class B common stock and are non-redeemable until the close of Business Combination. |
Warrant Liabilities
Warrant Liabilities | 9 Months Ended |
Sep. 30, 2023 | |
Warrant Liabilities [Abstract] | |
WARRANT LIABILITIES | NOTE 8. WARRANT LIABILITIES At September 30, 2023 and December 31, 2022, there were 7,880,925 Public Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless the shares of Class A common stock issuable upon such warrant exercise have been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement for the registration under the Securities Act of the shares of Class A common stock issuable upon exercise of the warrants and thereafter will use its commercially reasonable efforts to cause the same to become effective within 60 business days following a Business Combination and to maintain a current prospectus relating to the Class A common stock issuable upon exercise of the warrants, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60 th Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00. ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder; and ● if, and only if, the last reported sale price of the shares of Class A common stock for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities). If and when the warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of common stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration. Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00. ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table in the prospectus for the Initial Public Offering, based on the redemption date and the fair market value of the Class A common stock; ● if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities); and ● if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities) the Private Warrants must also be concurrently called for redemption on the same terms (except as described above with respect to a holder’s ability to cashless exercise its warrants) as the outstanding Public Warrants If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A common stock at a price below the exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of its initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively. As of September 30, 2023 and December 31, 2022, there were 297,618 Private Warrants outstanding. The Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants and the shares of Class A common stock issuable upon the exercise of the Private Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, and the holders thereof are entitled to certain registration rights. Additionally, so long as they are held by the initial purchasers or their permitted transferees, the Private Warrants: (i) will not be redeemable by the Company (except for certain limitations); (ii) may be exercised by the holders on a cashless basis; and (iii) with respect to Private Warrants held by the underwriters or their employees, will not be exercisable more than five years from the commencement of sales of the Initial Public Offering in accordance with FINRA Rule 5110(g)(8)(A). If the Private Warrants are held by holders other than the initial purchasers or their respective permitted transferees, the Private Warrants will be redeemable by the Company in all redemption scenarios and exercisable by such holders on the same basis as the Public Warrants. |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Sep. 30, 2023 | |
Fair Value Measurements [Abstract] | |
FAIR VALUE MEASUREMENTS | NOTE 9. FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, December 31, Assets: Marketable securities held in Trust Account 1 — $ 159,610,253 Liabilities: Warrant liability- Public Warrants 2 $ 236,427 $ 472,856 Warrant liability- Private Warrants 2 $ 8,928 $ 17,857 The Warrants were accounted for as liabilities in accordance with ASC Topic 815-40 and are presented within warrant liabilities in the accompanying condensed September 30, 2023 and December 31, 2022 balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the condensed statements of operations. On August 17, 2021, the “Public Warrants” were valued using a Monte Carlo Simulation model, which is considered to be a Level 3 fair value measurement. On August 17, 2021 and on December 31, 2021, the Private Warrants were valued using a Black Scholes model, considered a level 3 fair value measurement. The primary unobservable input utilized in determining the fair value of the Warrants is the expected volatility of the common stock. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. On December 31, subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price was used as the fair value of the Public Warrants. For periods subsequent to the detachment of the Public Warrants from the Units including September 30, 2023, the close price of the Public Warrant price was used as the fair value as of each relevant date. The Public Warrants were classified as Level 1 due to an active market price as of December 31, 2021. At September 30, 2023, Public Warrants were transferred to a level 2 due to the lack of an active market and the presence of observable inputs in surrounding periods for the same instrument. In addition, as of September 30, 2023, Private Warrants transferred to Level 2 due to a make-whole provision which allows the Company to use the value of the closing price of the Public Warrants. The following table presents the changes in the fair value of Level 3 warrant liabilities: Private Public Warrant Fair value as of December 31, 2021 $ 144,910 $ — $ 144,910 Change in valuation inputs or other assumptions (46,696 ) — (46,696 ) Transfer to level 2 (98,214 ) — (98,214 ) Fair value as of September 30, 2022 $ — $ — $ — Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. The estimated fair value of the Public Warrants transferred from a Level 1 measurement to a Level 2 fair value measurement during the three and nine months ended September 30, 2022 was $0 and $157,618, respectively. |
Subsequent Events
Subsequent Events | 9 Months Ended |
Sep. 30, 2023 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 10. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, other than described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements. On October 6, 2023, the Company engaged Maxim Group LLC (“Maxim”) to act as non-exclusive placement agent in connection with possible PIPE financing related to the Company’s initial Business Combination (the “PIPE Financing”). The Company will pay Maxim a cash fee payable upon the Closing equal to seven percent (7.0%) of the gross proceeds of the PIPE Financing, customary expense reimbursement up to $25,000 and warrants to purchase the same securities sold in the PIPE Financing that are equal to 5% of the total securities sold in the PIPE Financing. Such warrants will be exercisable starting six months after the Closing until five years after the Closing at a price per share equal to 100% of the price of the securities sold in the PIPE Financing. On November 13, 2023, the Form F-4 was declared effective by the SEC, and the Company then filed the definitive proxy statement/prospectus with the SEC and commenced the mailing of the definitive proxy statement/prospectus and other relevant documents to the Company’s stockholders as of November 6, 2023, the record date established for voting on the Proposed Business Combination. |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 9 Months Ended |
Sep. 30, 2023 | |
Summary of Significant Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in condensed financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on March 10, 2023. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the period ending December 31, 2023 or for any future periods. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of Estimates | Use of Estimates The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of September 30, 2023 and December 31, 2022, the Company had cash of $185,312 and $324,188, respectively. The Company did not have any cash equivalents at September 30, 2023 and December 31, 2022. |
Marketable Securities Held in Trust Account | Marketable Securities Held in Trust Account At September 30, 2023, substantially all of the assets held in the Trust Account were cash. At December 31, 2022, the assets held in the Trust Account were U.S. Treasury securities. From inception through September 30, 2023, the Company withdrew an amount of $1,613,646 in the interest income from the Trust Account to pay tax obligations. |
Offering Costs | Offering Costs Offering costs consist of underwriting, legal, accounting and other expenses incurred through the condensed balance sheet date that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to derivative warrant liabilities are expensed as incurred in the statements of operations. Offering costs associated with the Class A common stock issued were initially charged to temporary equity and then accreted to common stock subject to redemption upon the completion of the Initial Public Offering. Offering costs amounted to $9,292,595, of which $8,938,077 were charged to stockholders’ equity upon the completion of the Initial Public Offering and $354,518 were expensed to the statements of operations. |
Warrant Liabilities | Warrant Liabilities The Company accounts for the Public Warrants (as defined in Note 3) and the Private Warrants (as defined in Note 4) (collectively, with the Public Warrants, the “Warrants”) in accordance with the guidance contained in FASB Accounting Standards Codification (“ASC”) Topic 480 and FASB ASC Topic 815 “Derivatives and Hedging” (“ASC 815”) under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statements of operations. On August 17, 2021 and subsequently on September 30, 2021, the Public Warrants were valued using a Monte Carlo Simulation model. The Private Warrants were valued using a Black Scholes model at December 31, 2021. For periods subsequent to the detachment of the Public Warrants from the Units including September 30, 2023, the close price of the Public Warrant price was used as the fair value as of each relevant date. In addition, as of September 30, 2023, the closing price of the Public Warrants was determined to be an appropriate estimate for the fair value of Private Warrants due to a make-whole provision in the contractual terms of the Warrant Agreement. |
Income Taxes | Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement’s carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. |
Class A Common Stock Subject to Possible Redemption | Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2023 and December 31, 2022, 1,475,493 and 15,761,850 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, respectively, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. On April 20, 2023, the Company redeemed 14,286,357 shares of Class A common stock tendered for redemption by the Public Stockholders for a total redemption amount of $145,181,467 in connection with the implementation of the Extension, which is described in Note 1. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit. At September 30, 2023 and December 31, 2022, the Class A common stock reflected in the condensed balance sheets is reconciled in the following table: Shares Value Gross proceeds 15,761,850 $ 157,618,500 Less: Proceeds allocated to Public Warrants — (6,018,995 ) Class A common stock issuance costs — (8,768,627 ) Plus: Remeasurement of Class A common stock subject to possible redemption — 16,102,462 Class A common stock subject to possible redemption 12/31/22 15,761,850 158,933,340 Less: Redemption (14,286,357 ) (145,181,467 ) Plus: Remeasurement of Class A common stock subject to possible redemption — 1,651,653 Class A common stock subject to possible redemption 09/30/23 1,475,493 $ 15,403,526 |
Net (Loss) Income per Common Share | Net (Loss) Income per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per common share is computed by dividing net income by the weighted average number of shares of common stock outstanding for the period. Remeasurement associated with the redeemable shares of Class A common stock is excluded from net (loss) income per common share as the redemption value approximates fair value. The calculation of diluted (loss) income per share does not consider the effect of the Warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the Warrants is contingent upon the occurrence of future events. The Warrants are exercisable to purchase 8,178,543 shares of Class A common stock in the aggregate. As of September 30, 2023 and 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common shares and then share in the net (loss) income of the Company. As a result, diluted net (loss) income per common share is the same as basic net (loss) income per common share for the periods presented. The following table reflects the calculation of basic and diluted net (loss) income per common share (in dollars, except per share amounts): For the Three Months For the Nine Months Ended September 30, Ended September 30, 2023 2022 2023 2022 Class A Common Stock subject to possible redemption Numerator: Net (loss) income allocable to Class A common stock $ (129,977 ) $ 469,586 $ 203,525 $ 2,046,030 Denominator: Weighted Average Class A common stock Basic and diluted weighted average shares outstanding 2,070,730 16,357,087 7,984,131 16,357,087 Basic and diluted net income (loss) per share $ (0.06 ) $ 0.03 $ 0.03 $ 0.13 Class A Common Stock Numerator: Net loss allocable to Class A common stock (247,338 ) — 60,342 — Denominator: Weighted Average Class A common stock - 3,940,462 — 2,367,164 — Basic and diluted net income (loss) per share $ (0.06 ) $ — $ 0.03 $ — Class B Common Stock Numerator: Net (loss) income allocable to Class B common stock — 113,124 40,473 492,894 Denominator: Weighted Average Class B common stock - Basic and diluted weighted average shares outstanding — 3,940,462 1,587,732 3,940,462 Basic and diluted net income per share $ — $ 0.03 $ 0.03 $ 0.13 |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature, except for warrant liabilities (see Note 9). |
Recent Accounting Standards | Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Summary of Significant Accounting Policies [Abstract] | |
Schedule of Class A Common Stock Reflected in the Condensed Balance Sheet | At September 30, 2023 and December 31, 2022, the Class A common stock reflected in the condensed balance sheets is reconciled in the following table: Shares Value Gross proceeds 15,761,850 $ 157,618,500 Less: Proceeds allocated to Public Warrants — (6,018,995 ) Class A common stock issuance costs — (8,768,627 ) Plus: Remeasurement of Class A common stock subject to possible redemption — 16,102,462 Class A common stock subject to possible redemption 12/31/22 15,761,850 158,933,340 Less: Redemption (14,286,357 ) (145,181,467 ) Plus: Remeasurement of Class A common stock subject to possible redemption — 1,651,653 Class A common stock subject to possible redemption 09/30/23 1,475,493 $ 15,403,526 |
Schedule of Basic and Diluted Net (Loss) Income Per Common Share | The following table reflects the calculation of basic and diluted net (loss) income per common share (in dollars, except per share amounts): For the Three Months For the Nine Months Ended September 30, Ended September 30, 2023 2022 2023 2022 Class A Common Stock subject to possible redemption Numerator: Net (loss) income allocable to Class A common stock $ (129,977 ) $ 469,586 $ 203,525 $ 2,046,030 Denominator: Weighted Average Class A common stock Basic and diluted weighted average shares outstanding 2,070,730 16,357,087 7,984,131 16,357,087 Basic and diluted net income (loss) per share $ (0.06 ) $ 0.03 $ 0.03 $ 0.13 Class A Common Stock Numerator: Net loss allocable to Class A common stock (247,338 ) — 60,342 — Denominator: Weighted Average Class A common stock - 3,940,462 — 2,367,164 — Basic and diluted net income (loss) per share $ (0.06 ) $ — $ 0.03 $ — Class B Common Stock Numerator: Net (loss) income allocable to Class B common stock — 113,124 40,473 492,894 Denominator: Weighted Average Class B common stock - Basic and diluted weighted average shares outstanding — 3,940,462 1,587,732 3,940,462 Basic and diluted net income per share $ — $ 0.03 $ 0.03 $ 0.13 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Fair Value Measurements [Abstract] | |
Schedule of Fair Value Hierarchy of The Valuation Inputs | The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, December 31, Assets: Marketable securities held in Trust Account 1 — $ 159,610,253 Liabilities: Warrant liability- Public Warrants 2 $ 236,427 $ 472,856 Warrant liability- Private Warrants 2 $ 8,928 $ 17,857 |
Schedule of Changes in Fair Value of Warrant Liabilities | The following table presents the changes in the fair value of Level 3 warrant liabilities: Private Public Warrant Fair value as of December 31, 2021 $ 144,910 $ — $ 144,910 Change in valuation inputs or other assumptions (46,696 ) — (46,696 ) Transfer to level 2 (98,214 ) — (98,214 ) Fair value as of September 30, 2022 $ — $ — $ — |
Description of Organization, _2
Description of Organization, Business Operations and Going Concern (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 9 Months Ended | ||||||||
Apr. 12, 2023 | Apr. 30, 2023 | Apr. 20, 2023 | Aug. 16, 2022 | Aug. 25, 2021 | Aug. 17, 2021 | Mar. 31, 2023 | Sep. 30, 2023 | Sep. 30, 2022 | Apr. 18, 2023 | Dec. 31, 2022 | |
Description of Organization, Business Operations and Going Concern (Details) [Line Items] | |||||||||||
Business combination number of businesses minimum | one or more businesses | ||||||||||
Price per share (in Dollars per share) | $ 10 | ||||||||||
Transaction costs | $ 9,292,595 | ||||||||||
Underwriting fees | 3,152,370 | ||||||||||
Net of reimbursement | 5,516,648 | ||||||||||
Other offering costs | $ 623,577 | ||||||||||
Deferred underwriting commissions | $ 4,046,657 | ||||||||||
Deferred underwriting fees | 245,002 | ||||||||||
Deferred underwriting discount. | $ 3,801,655 | ||||||||||
Shares issued (in Shares) | 150,000 | ||||||||||
Aggregate shares issued (in Shares) | 300,000 | ||||||||||
Investments maximum maturity term | 185 days | ||||||||||
Redeemtion of shares (in Shares) | 14,286,357 | ||||||||||
Fair market value, percentage | 80% | ||||||||||
Percentage of restricted redeeming shares | 15% | ||||||||||
Aggregate redemption amount | $ 145.2 | ||||||||||
Dissolution expenses | $ 100,000 | ||||||||||
Cash deposited in Trust Account per Unit. (in Dollars per share) | $ 10 | ||||||||||
Operating bank account | $ 185,312 | $ 324,188 | |||||||||
Working capital deficit | 1,731,225 | ||||||||||
Deposit in trust account | 551,066 | ||||||||||
Interest income from the trust account | $ 1,613,646 | ||||||||||
U.S. government treasury bills Maximum Maturity Term | 185 days | ||||||||||
U.S. federal excise tax | 1% | ||||||||||
Excise tax fair market value of shares repurchased | 1% | ||||||||||
Total redemption amount | $ 145,181,467 | $ 145,181,467 | |||||||||
Excise tax liability | $ 1,451,815 | ||||||||||
Excise tax liability rate | 1% | ||||||||||
Initial Public Offering [Member] | |||||||||||
Description of Organization, Business Operations and Going Concern (Details) [Line Items] | |||||||||||
Price per share (in Dollars per share) | $ 10 | ||||||||||
Sale of units (in Shares) | 15,761,850 | ||||||||||
Sale of price per share (in Dollars per share) | $ 10 | ||||||||||
Net proceeds | $ 150,000,000 | ||||||||||
Price per share (in Dollars per share) | $ 10 | ||||||||||
Private Placement Units [Member] | |||||||||||
Description of Organization, Business Operations and Going Concern (Details) [Line Items] | |||||||||||
Sale of units (in Shares) | 15,237 | 580,000 | |||||||||
Sale of price per share (in Dollars per share) | $ 10 | $ 10 | |||||||||
Gross proceeds | $ 152,370 | $ 5,800,000 | |||||||||
Price per share (in Dollars per share) | $ 10 | ||||||||||
Over-Allotment Option [Member] | |||||||||||
Description of Organization, Business Operations and Going Concern (Details) [Line Items] | |||||||||||
Price per share (in Dollars per share) | $ 10 | ||||||||||
Gross proceeds | $ 7,618,500 | ||||||||||
Sale of units (in Shares) | 761,850 | ||||||||||
Sale of price per share (in Dollars per share) | $ 10 | ||||||||||
Gross proceeds | $ 7,618,500 | ||||||||||
Additional units (in Shares) | 761,850 | ||||||||||
Deposit in the trust Account | $ 157,618,500 | ||||||||||
Class A Common Stock [Member] | |||||||||||
Description of Organization, Business Operations and Going Concern (Details) [Line Items] | |||||||||||
Additional units (in Shares) | 6,011,192 | ||||||||||
Redeemtion of shares (in Shares) | 1,475,493 | 14,286,357 | 15,761,850 | ||||||||
Common stock redemption price per share (in Dollars per share) | $ 10.16 | ||||||||||
Aggregate redeemed amount | $ 145,200,000 | ||||||||||
Number of stock bought back by the entity at the redemption price (in Shares) | 14,286,357 | ||||||||||
Redemption Price (in Dollars per share) | $ 10.16 | ||||||||||
Total redemption amount | $ 145,181,467 | ||||||||||
Class A Common Stock [Member] | Initial Public Offering [Member] | |||||||||||
Description of Organization, Business Operations and Going Concern (Details) [Line Items] | |||||||||||
Share issued (in Shares) | 15,000,000 | ||||||||||
Price per share (in Dollars per share) | $ 10 | ||||||||||
Gross proceeds | $ 150,000,000 | ||||||||||
Class B Common Stock [Member] | |||||||||||
Description of Organization, Business Operations and Going Concern (Details) [Line Items] | |||||||||||
Conversion of stock, shares converted (in Shares) | 6,011,192 | ||||||||||
Business Combination [Member] | |||||||||||
Description of Organization, Business Operations and Going Concern (Details) [Line Items] | |||||||||||
Share price (in Dollars per share) | $ 4.9 | ||||||||||
underwriting agreement amount | $ 1,469,991 | ||||||||||
Business combination voting percentage | 50% | ||||||||||
Net tangible assets of business combination | 5,000,001% | ||||||||||
Company's obligation to redeemed, percentage | 100% |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Details) - USD ($) | 1 Months Ended | 9 Months Ended | |||
Apr. 20, 2023 | Sep. 30, 2023 | Sep. 30, 2022 | Apr. 18, 2023 | Dec. 31, 2022 | |
Summary of Significant Accounting Policies (Details) [Line Items] | |||||
Cash | $ 185,312 | $ 324,188 | |||
Interest income | 1,613,646 | ||||
Offering cost | 9,292,595 | ||||
Charge of stockholder's equity | 8,938,077 | ||||
Operating expenses | 354,518 | ||||
Shares subject to possible redemption (in Shares) | 14,286,357 | ||||
Redemption amount | $ 145,181,467 | 145,181,467 | |||
Federal depository insurance corporation coverage | $ 250,000 | ||||
Class A Common Stock [Member] | |||||
Summary of Significant Accounting Policies (Details) [Line Items] | |||||
Shares subject to possible redemption (in Shares) | 1,475,493 | 14,286,357 | 15,761,850 | ||
Redemption amount | $ 145,181,467 | ||||
Common stock shares (in Shares) | 8,178,543 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Details) - Schedule of Class A Common Stock Reflected in the Condensed Balance Sheet - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Schedule Of Class ACommon Stock Reflected In The Condensed Balance Sheet Abstract | ||
Gross proceeds, shares | 15,761,850 | |
Gross proceeds | $ 157,618,500 | |
Less: | ||
Proceeds allocated to Public Warrants, shares | ||
Proceeds allocated to Public Warrants | $ (6,018,995) | |
Class A common stock issuance costs, shares | ||
Class A common stock issuance costs | $ (8,768,627) | |
Plus: | ||
Remeasurement of Class A common stock subject to possible redemption, shares | ||
Remeasurement of Class A common stock subject to possible redemption | $ 1,651,653 | $ 16,102,462 |
Class A common stock subject to possible redemption, shares | 1,475,493 | 15,761,850 |
Class A common stock subject to possible redemption | $ 15,403,526 | $ 158,933,340 |
Less: | ||
Redemption, shares | (14,286,357) | |
Redemption | $ (145,181,467) |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net (Loss) Income Per Common Share - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Class A Common Stock Redeemable [Member] | ||||
Class A Common Stock subject to possible redemption | ||||
Numerator: Net loss allocable to common stock | $ (129,977) | $ 469,586 | $ 203,525 | $ 2,046,030 |
Denominator: Weighted Average Class A common stock | ||||
Basic weighted average shares outstanding | 2,070,730 | 16,357,087 | 7,984,131 | 16,357,087 |
Basic net income (loss) per share | $ (0.06) | $ 0.03 | $ 0.03 | $ 0.13 |
Class A Common Stock [Member] | ||||
Class A Common Stock subject to possible redemption | ||||
Numerator: Net loss allocable to common stock | $ (247,338) | $ 60,342 | ||
Denominator: Weighted Average Class A common stock | ||||
Basic weighted average shares outstanding | 3,940,462 | 2,367,164 | ||
Basic net income (loss) per share | $ (0.06) | $ 0.03 | ||
Class B Common Stock [Member] | ||||
Class A Common Stock subject to possible redemption | ||||
Numerator: Net loss allocable to common stock | $ 113,124 | $ 40,473 | $ 492,894 | |
Denominator: Weighted Average Class A common stock | ||||
Basic weighted average shares outstanding | 3,940,462 | 1,587,732 | 3,940,462 | |
Basic net income (loss) per share | $ 0.03 | $ 0.03 | $ 0.13 |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net (Loss) Income Per Common Share (Parentheticals) - $ / shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Class A Common Stock Redeemable [Member] | ||||
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net (Loss) Income Per Common Share (Parentheticals) [Line Items] | ||||
Diluted weighted average shares outstanding | 2,070,730 | 16,357,087 | 7,984,131 | 16,357,087 |
Diluted net income (loss) per share | $ (0.06) | $ 0.03 | $ 0.03 | $ 0.13 |
Class A Common Stock [Member] | ||||
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net (Loss) Income Per Common Share (Parentheticals) [Line Items] | ||||
Diluted weighted average shares outstanding | 3,940,462 | 2,367,164 | ||
Diluted net income (loss) per share | $ (0.06) | $ 0.03 | ||
Class B Common Stock [Member] | ||||
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net (Loss) Income Per Common Share (Parentheticals) [Line Items] | ||||
Diluted weighted average shares outstanding | 3,940,462 | 1,587,732 | 3,940,462 | |
Diluted net income (loss) per share | $ 0.03 | $ 0.03 | $ 0.13 |
Initial Public Offering (Detail
Initial Public Offering (Details) - $ / shares | 9 Months Ended | |
Sep. 30, 2023 | Aug. 25, 2021 | |
Initial Public Offering [Member] | ||
Initial Public Offering (Details) [Line Items] | ||
Sale of stock | 15,761,850 | |
Sale of stock price per share | $ 10 | |
Over-Allotment Option [Member] | ||
Initial Public Offering (Details) [Line Items] | ||
Sale of stock | 761,850 | |
Sale of stock price per share | $ 10 | |
Class A Common Stock [Member] | ||
Initial Public Offering (Details) [Line Items] | ||
Exercise price | $ 11.5 |
Private Placement (Details)
Private Placement (Details) | 9 Months Ended |
Sep. 30, 2023 USD ($) $ / shares | |
Private Placement (Details) [Line Items] | |
Warrant price per share | $ / shares | $ 11.5 |
Private Placement [Member] | |
Private Placement (Details) [Line Items] | |
Purchase aggregate price | $ | $ 595,237 |
Purchase price of per unit | $ / shares | $ 10 |
Aggregate purchase price | $ | $ 5,952,370 |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||
Aug. 12, 2021 | Jul. 07, 2020 | Aug. 25, 2021 | Jul. 23, 2021 | Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2020 | Jun. 24, 2020 | |
Related Party Transactions (Details) [Line Items] | ||||||||||
Sponsor forfeited shares | 1,437,500 | |||||||||
Founder shares outstanding | 4,312,500 | |||||||||
Shares subject to forfeiture | 562,500 | |||||||||
Shares are longer subject to forfeiture | 190,462 | |||||||||
Aggregate of founder shares outstanding | 3,940,462 | |||||||||
Founder shares, description | (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. | |||||||||
Purchased share | 13,365,000 | |||||||||
Founder shares | 100,000 | |||||||||
Aggregate founder shares | 900,000 | |||||||||
Offering costs (in Dollars) | $ 4,464,000 | |||||||||
Transaction costs (in Dollars) | 170,341 | |||||||||
Additional paid in capital (in Dollars) | $ 4,296,659 | 4,296,659 | ||||||||
Accumulated deficit (in Dollars) | 170,341 | 170,341 | ||||||||
Office space utilities (in Dollars) | $ 15,000 | |||||||||
Incurred services (in Dollars) | 45,000 | $ 45,000 | 135,000 | $ 135,000 | ||||||
Aggregate principal amount (in Dollars) | $ 250,000 | |||||||||
Working capital loans (in Dollars) | $ 1,500,000 | $ 1,500,000 | ||||||||
Working capital loan description | As of September 30, 2023 and December 31, 2022, there were no Working Capital Loans outstanding. | |||||||||
Working Capital Loans [Member] | ||||||||||
Related Party Transactions (Details) [Line Items] | ||||||||||
Convertible units (in Dollars per share) | $ 10 | $ 10 | ||||||||
Over-Allotment Option [Member] | ||||||||||
Related Party Transactions (Details) [Line Items] | ||||||||||
Underwriters purchased | 761,850 | |||||||||
Additional unit price (in Dollars per share) | $ 10 | |||||||||
Aggregate shares forfeited | 372,038 | |||||||||
Aggregate of founder shares outstanding | 3,940,462 | |||||||||
Common stock issued | 761,850 | |||||||||
Over-Allotment Option [Member] | Founder Shares [Member] | ||||||||||
Related Party Transactions (Details) [Line Items] | ||||||||||
Aggregate shares forfeited | 372,038 | |||||||||
Shares are longer subject to forfeiture | 190,462 | |||||||||
IPO [Member] | ||||||||||
Related Party Transactions (Details) [Line Items] | ||||||||||
Underwriters purchased | 15,761,850 | |||||||||
Additional unit price (in Dollars per share) | $ 10 | $ 10 | ||||||||
Aggregate shares | 15,761,850 | 15,761,850 | ||||||||
Class B Common Stock [Member] | ||||||||||
Related Party Transactions (Details) [Line Items] | ||||||||||
Stockholders purchased shares | 5,750,000 | |||||||||
Aggregate price (in Dollars) | $ 25,000 | |||||||||
Aggregate of shares | 240,001 | |||||||||
Shares subject to forfeiture | 562,500 | |||||||||
Common stock outstanding | 0 | 0 | ||||||||
Class A Common Stock [Member] | ||||||||||
Related Party Transactions (Details) [Line Items] | ||||||||||
Stockholders purchased shares | 8,178,543 | 8,178,543 | ||||||||
Common stock issued | 6,011,192 | 6,011,192 | ||||||||
Investors [Member] | ||||||||||
Related Party Transactions (Details) [Line Items] | ||||||||||
Fair value of the founder shares (in Dollars) | $ 4,464,000 | |||||||||
Investors [Member] | IPO [Member] | ||||||||||
Related Party Transactions (Details) [Line Items] | ||||||||||
Per per share (in Dollars per share) | $ 4.96 | |||||||||
Underwriting Agreement [Member] | Over-Allotment Option [Member] | ||||||||||
Related Party Transactions (Details) [Line Items] | ||||||||||
Underwriters purchased | 761,850 |
Commitments and Contingencies (
Commitments and Contingencies (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 9 Months Ended | |||||||
Apr. 12, 2023 | Aug. 12, 2021 | Mar. 31, 2023 | Aug. 25, 2021 | Sep. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Commitments and Contingencies (Details) [Line Items] | ||||||||||
Additional purchase of units (in Shares) | 300,000 | |||||||||
Deferred underwriting commissions | $ 4,046,657 | |||||||||
Deferred underwriting fees | $ (245,002) | |||||||||
Deferred underwriting discount | $ 3,801,655 | 4,046,656 | ||||||||
Aggregate shares (in Shares) | 300,000 | |||||||||
Accrued fees | $ 1,555,000 | $ 1,555,000 | $ 758,955 | |||||||
Filament shares | 43% | 43% | ||||||||
Working capital Loans | $ 500,000 | $ 500,000 | ||||||||
Underwriting Agreement [Member] | ||||||||||
Commitments and Contingencies (Details) [Line Items] | ||||||||||
Deferred fee per unit (in Dollars per share) | $ 0.35 | |||||||||
Deferred fee | $ 5,516,648 | $ 5,516,648 | ||||||||
Business Combination [Member] | ||||||||||
Commitments and Contingencies (Details) [Line Items] | ||||||||||
Deferred underwriting fees | 245,002 | |||||||||
Deferred underwriting discount | $ 3,801,655 | |||||||||
Underwriting payable | $ 1,469,991 | |||||||||
Over-Allotment Option [Member] | ||||||||||
Commitments and Contingencies (Details) [Line Items] | ||||||||||
Additional purchase of units (in Shares) | 2,250,000 | |||||||||
Additional units purchased (in Shares) | 761,850 | |||||||||
Brookline [Member] | Underwriting Agreement [Member] | ||||||||||
Commitments and Contingencies (Details) [Line Items] | ||||||||||
Underwriting agreement common shares (in Shares) | 150,000 | |||||||||
Ladenburg [Member] | Underwriting Agreement [Member] | ||||||||||
Commitments and Contingencies (Details) [Line Items] | ||||||||||
Common share price per share (in Dollars per share) | $ 4.9 |
Stockholders_ Deficit (Details)
Stockholders’ Deficit (Details) - $ / shares | 1 Months Ended | 9 Months Ended | 12 Months Ended | |||
Aug. 25, 2021 | Sep. 30, 2023 | Dec. 31, 2020 | Apr. 20, 2023 | Apr. 18, 2023 | Dec. 31, 2022 | |
Stockholders’ Deficit (Details) [Line Items] | ||||||
Preferred stock, shares authorized | 1,000,000 | 1,000,000 | ||||
Preferred stock par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | ||||
Common stock subject to possible redemption | 14,286,357 | |||||
Subject to forfeiture shares | 562,500 | |||||
Founder shares subject to forfeited | 190,462 | |||||
Founder shares outstanding | 3,940,462 | |||||
Over-Allotment Option [Member] | ||||||
Stockholders’ Deficit (Details) [Line Items] | ||||||
Founder shares forfeited | 372,038 | |||||
Founder shares outstanding | 3,940,462 | |||||
Common stock issued | 761,850 | |||||
Class A Common Stock [Member] | ||||||
Stockholders’ Deficit (Details) [Line Items] | ||||||
Common stock, shares authorized | 100,000,000 | 100,000,000 | ||||
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | ||||
Common stock, shares issued | 4,535,699 | 595,237 | ||||
Common stock, shares outstanding | 4,535,699 | 595,237 | ||||
Common stock subject to possible redemption | 1,475,493 | 14,286,357 | 15,761,850 | |||
Common stock issued | 6,011,192 | |||||
Class B Common Stock [Member] | ||||||
Stockholders’ Deficit (Details) [Line Items] | ||||||
Common stock, shares authorized | 10,000,000 | 10,000,000 | ||||
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | ||||
Common stock, shares issued | 0 | 4,312,500 | 3,940,462 | |||
Common stock, shares outstanding | 0 | 4,312,500 | 3,940,462 | |||
Subject to forfeiture shares | 562,500 | |||||
Issued and outstanding common stock percentage | 20% | |||||
Converted basis percentage | 20% | |||||
Common stock outstanding | 0 |
Warrant Liabilities (Details)
Warrant Liabilities (Details) - $ / shares | 9 Months Ended | |
Sep. 30, 2023 | Dec. 31, 2022 | |
Warrant Liabilities (Details) [Line Items] | ||
Public warrants outstanding (in Shares) | 7,880,925 | 7,880,925 |
Warrant price per share | $ 11.5 | |
Exceeds per share | 10 | |
Price per share | 10 | |
Reference value per share | 18 | |
Shares issued Price Per Share | $ 10 | |
Trading day period to calculate volume weighted average trading price | 20 days | |
Class A Common Stock [Member] | ||
Warrant Liabilities (Details) [Line Items] | ||
Redemption of warrants price per share | $ 18 | |
Warrant price per share | 0.1 | |
Exceeds per share | 18 | |
Class A Common Stock [Member] | Public Warrants [Member] | ||
Warrant Liabilities (Details) [Line Items] | ||
Warrant price per share | 0.01 | |
Class A Common Stock [Member] | Additional Offering [Member] | ||
Warrant Liabilities (Details) [Line Items] | ||
Shares issued Price Per Share | $ 9.2 | |
Percentage of gross proceeds on total equity proceeds | 60% | |
Volume weighted average price per share | $ 9.2 | |
Public Warrants [Member] | ||
Warrant Liabilities (Details) [Line Items] | ||
Adjusted exercise price of warrants percentage | 115% | |
Public Warrants [Member] | Class A Common Stock [Member] | Minimum [Member] | ||
Warrant Liabilities (Details) [Line Items] | ||
Redemption trigger price | $ 10 | |
Adjusted share price percentage | 100% | |
Public Warrants [Member] | Class A Common Stock [Member] | Maximum [Member] | ||
Warrant Liabilities (Details) [Line Items] | ||
Redemption trigger price | $ 18 | |
Adjusted share price percentage | 180% | |
Private Warrants [Member] | ||
Warrant Liabilities (Details) [Line Items] | ||
Public warrants outstanding (in Shares) | 297,618 | 297,618 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) | 3 Months Ended | 9 Months Ended |
Sep. 30, 2023 | Sep. 30, 2023 | |
Fair Value Measurements [Abstract] | ||
Fair value measurement | $ 0 | $ 157,618 |
Fair Value Measurements (Deta_2
Fair Value Measurements (Details) - Schedule of Fair Value Hierarchy of The Valuation Inputs - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Level 1 [Member] | ||
Assets: | ||
Marketable securities held in Trust Account | $ 159,610,253 | |
Level 2 [Member] | ||
Liabilities: | ||
Warrant liability- Public Warrants | 236,427 | 472,856 |
Warrant liability- Private Warrants | $ 8,928 | $ 17,857 |
Fair Value Measurements (Deta_3
Fair Value Measurements (Details) - Schedule of Changes in Fair Value of Warrant Liabilities | 9 Months Ended |
Sep. 30, 2022 USD ($) | |
Private Placement [Member] | |
Fair Value Measurements (Details) - Schedule of Changes in Fair Value of Warrant Liabilities [Line Items] | |
Fair value beginning balance | $ 144,910 |
Change in valuation inputs or other assumptions | (46,696) |
Transfer to level 2 | (98,214) |
Fair value ending balance | |
Public [Member] | |
Fair Value Measurements (Details) - Schedule of Changes in Fair Value of Warrant Liabilities [Line Items] | |
Fair value beginning balance | |
Change in valuation inputs or other assumptions | |
Transfer to level 2 | |
Fair value ending balance | |
Warrant Liabilities [Member] | |
Fair Value Measurements (Details) - Schedule of Changes in Fair Value of Warrant Liabilities [Line Items] | |
Fair value beginning balance | 144,910 |
Change in valuation inputs or other assumptions | (46,696) |
Transfer to level 2 | (98,214) |
Fair value ending balance |
Subsequent Events (Details)
Subsequent Events (Details) - Subsequent Event [Member] | Oct. 06, 2023 USD ($) |
Subsequent Events (Details) [Line Items] | |
Gross proceeds percentage | 7% |
Customary expense reimbursement (in Dollars) | $ 25,000 |
Total securities sold in PIPE financing percentage | 5% |
Securities sold in PIPE financing percentage | 100% |